Monopar Therapeutics Inc.

MNPR | NASDAQ

Price Alert Chart Builder DCF Calculator

$95.72

-$0.75 (-0.78%)

At close: Sep 21, 2026, 4:00 PM ET

$95.15

-$0.57 (-0.60%)

Pre-market: Sep 22, 2026, 6:54 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $646.26M

Enterprise Value $507.04M

Beta 1.50

Average Volume 206.22K

Shares Outstanding (Diluted) 8.54M

Shares Change YoY 22.07%

Institutional Ownership 73.06%

Exchange NASDAQ

ISIN US61023L2079

Price Performance

Price Change 1M -10.5%

Price Change 3M 17.1%

Price Change 6M 68.1%

Price Change YTD 45.0%

Price Change 1Y 50.4%

Price Change 3Y 3144.8%

Price Change 5Y 273.9%

1M CAGR (ann.) -19.8%

1Y CAGR (ann.) 44.8%

5Y CAGR (ann.) 28.3%

All-Time CAGR -4.6%

Valuation

PE Ratio -40.91

Forward PE N/A

PEG Ratio 1.44

Forward PEG 2.75

PS Ratio N/A

Forward PS 23.00

PB Ratio 4.90

P/FCF Ratio -0.20

P/Adj. FCF Ratio -0.14

P/OCF Ratio -0.25

EV/Sales N/A

EV/EBIT -27.41

EV/EBITDA -27.41

EV/FCF -0.16

Earnings Yield -2.4%

FCF Yield -507.8%

Adj. FCF Yield -731.2%

Financial Health

Net Cash $134.3M

Total Debt $107.83K

Cash & Short-Term Investments $134.3M

Total Assets $134.98M

Current Ratio 33.56

Quick Ratio 33.56

Debt / Equity Ratio 0.00

Debt / EBITDA -0.01

Debt / FCF -0.00

OCF / Debt -30,199.40

Interest Coverage 0.00

Altman Z-Score 93.71

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -44.0%

Returns

Return on Assets -13.2%

Return on Equity -13.1%

Return on Invested Capital -16.9%

Return on Capital Employed -16.9%

Return on Tangible Assets -13.2%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -59.2%

EPS CAGR 5Y -32.7%

EPS CAGR 10Y -14.2%

FCF CAGR 3Y -148.9%

FCF CAGR 5Y -98.8%

FCF CAGR 10Y -53.9%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 14

EPS Growth Next 3Y 42.3%

Revenue Growth Next 3Y N/A

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $126

Price Target Upside 31.6%

Cash Flow

Operating Cash Flow $-3.26B

Free Cash Flow $-3.26B

Adj. Free Cash Flow $-4.69B

FCF Per Share -$381.20

OCF Per Share -$381.20

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-22.12M

EBITDA $-18.5M

Net Income $-17.84M

EPS (Diluted) -$2.34

Revenue / Employee N/A

Profit / Employee $-811.12K

Employees 22